Radioiodine-refractory Thyroid Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-04-01
Clinical Trial Update: Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer [Phase 1]
Phase 1 clinical trial evaluating Lutetium-177 DOTA-EB-FAPI in patients with metastatic, radioiodine-refractory thyroid cancer has completed…